As of 2025-07-23, the Relative Valuation of Guangzhou LBP Medicine Science & Technology Co Ltd (688393.SS) is 3.75 CNY. This relative valuation is based on P/E multiples. With the latest stock price at 32.59 CNY, the upside of Guangzhou LBP Medicine Science & Technology Co Ltd based on Relative Valuation is -88.5%.
The range of the Relative Valuation is 1.08 - 7.33 CNY.
| Range | Selected | |
| Trailing P/E multiples | 45.2x - 74.4x | 60.1x |
| Forward P/E multiples | 29.8x - 41.3x | 34.2x |
| Fair Price | 1.08 - 7.33 | 3.75 |
| Upside | -96.7% - -77.5% | -88.5% |
| Date | P/E |
| 2025-07-16 | 1,260.42 |
| 2025-07-15 | 1,292.20 |
| 2025-07-14 | 1,216.93 |
| 2025-07-11 | 1,238.67 |
| 2025-07-10 | 1,193.09 |
| 2025-07-09 | 1,203.13 |
| 2025-07-08 | 1,213.16 |
| 2025-07-07 | 1,196.02 |
| 2025-07-04 | 1,224.87 |
| 2025-07-03 | 1,190.58 |
| 2025-07-02 | 1,188.07 |
| 2025-07-01 | 1,235.33 |
| 2025-06-30 | 1,201.87 |
| 2025-06-27 | 1,198.53 |
| 2025-06-26 | 1,157.54 |
| 2025-06-25 | 1,158.80 |
| 2025-06-24 | 1,134.54 |
| 2025-06-23 | 1,099.83 |
| 2025-06-20 | 1,087.29 |
| 2025-06-19 | 1,149.60 |
| 2025-06-18 | 1,190.58 |
| 2025-06-17 | 1,211.07 |
| 2025-06-16 | 1,230.31 |
| 2025-06-13 | 1,184.73 |
| 2025-06-12 | 1,247.46 |
| 2025-06-11 | 1,188.49 |
| 2025-06-10 | 1,185.56 |
| 2025-06-09 | 1,244.95 |
| 2025-06-06 | 1,195.60 |
| 2025-06-05 | 1,232.82 |
| 2025-06-04 | 1,192.25 |
| 2025-06-03 | 1,196.44 |
| 2025-05-30 | 1,173.85 |
| 2025-05-29 | 1,196.02 |
| 2025-05-28 | 1,145.84 |
| 2025-05-27 | 1,166.33 |
| 2025-05-26 | 1,206.89 |
| 2025-05-23 | 1,218.18 |
| 2025-05-22 | 1,204.38 |
| 2025-05-21 | 1,235.33 |
| 2025-05-20 | 1,252.06 |
| 2025-05-19 | 1,243.69 |
| 2025-05-16 | 1,295.96 |
| 2025-05-15 | 1,289.27 |
| 2025-05-14 | 1,360.78 |
| 2025-05-13 | 1,385.46 |
| 2025-05-12 | 1,292.20 |
| 2025-05-09 | 1,291.36 |
| 2025-05-08 | 1,349.07 |
| 2025-05-07 | 1,339.04 |